EP0888287A1 - Verfahren zur reinigung von einem zwischenprodukt zur herstellung von iodhaltigem kontrastmittel - Google Patents
Verfahren zur reinigung von einem zwischenprodukt zur herstellung von iodhaltigem kontrastmittelInfo
- Publication number
- EP0888287A1 EP0888287A1 EP97953838A EP97953838A EP0888287A1 EP 0888287 A1 EP0888287 A1 EP 0888287A1 EP 97953838 A EP97953838 A EP 97953838A EP 97953838 A EP97953838 A EP 97953838A EP 0888287 A1 EP0888287 A1 EP 0888287A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- water
- soluble
- compound
- purification
- alcohol solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
Definitions
- the present invention relates to a process for the purification of an intermediate useful in the synthesis of iodinated contrast media, more particularly to a process for the purification of the compound -5-(2- acetoxy-propionylamino)-2,4,6-triiodo-isophthaloyl di- chloride (hereinafter referred to as compound A).
- Compound A disclosed in British Patent n° 1,472,050 (Savac AG), is an intermediate for the synthesis of ( S )-N,N ' -bis[2-hydroxy-( 1-hydroxymethyl )- ethyl]-5-( 2-hydroxypropionylamino )-2 ,4 , 6-triiodo-iso- phthalamide, an X-ray non-ionic contrast medium, also known under the non-proprietary name iopamidol.
- the industrial synthesis of compound A still follows the synthetic scheme disclosed in British Patent n° 1,472,050, consisting in the following steps:
- the recovery of crude compound A according to what described in British Patent n. 1,472,050 is effected by partial evaporation of the solvent, treatment with water and ice and filtration of the crystalline precipitate which has however to be further purified by suspension in warm chloroform.
- the warm treatment with a chlorinated, highly toxic solvent is clearly industrially unsuitable from the economic and environmental point of views.
- the resulting compound A is particularly pure, having a high enantiomeric purity, i.e. an e. e. higher than 92%.
- the water-soluble C 2 ⁇ C 5 alcohol solvent is selected from propanol, isopropanol, n-butanol, sec-butanol, isobutanol, tert-butanol , 2-ethoxyethanol ( cellosolve ) , 2-methoxyethanol ( ethylcellosolve ) .
- 2-Ethoxyethanol (cellosolve) is preferably used.
- the amount of water- soluble C,-Cr alcohol solvent generally ranges from 20% to 80% on the basis of the reaction mixture volume, preferably from 40% to 60%.
- the dilution of the reaction mixture with a water-soluble C 3 -C 5 alcohol solvent is carried out at low temperatures, generally from 0°C to 20°C, preferably from 5°C to 10°C.
- the resulting solution is added to a water amount 2-5 times the volume of the solution itself.
- the addition to water is carried out at a temperature from 10°C to 20°C, preferably from 15°C to 20°C.
- the resulting suspension is filtered to obtain pure compound A.
- the whole purification process is extremely simple and involves no separation of the phases, i.e. it makes use of water-soluble organic solvents.
- the solvent used in the purification process of the present invention is an alcohol solvent which could react directly with compound A thus yielding side- products.
- compound A is obtained in a pure form.
- this process allows to obtain compound A with a high enantio eric purity, i.e. an enantiomeric purity degree suitable for the subsequent use in the synthesis of iopamidol, to obtain iopamidol with a rotatory power fulfilling the requirements of Pharmacopoeia.
- the process of the invention is also suitable for the purification and the recovery of compound A from reaction mixtures containing halo acids.
- a further object of the invention is a process for the preparation of iopamidol, which process comprises the preparation of compound L-5-( 2-acetoxypropio- nylamino)-2,4, 6-triiodoisophthaloyl dichloride by reaction between L-2-acetoxypropionyl chloride and 5- amino-2,4,6-triiodo-isophthaloyl dichloride in N,N- dimethylaceta ide and the purification thereof diluting the reaction mixture with a water-soluble 3 ⁇ C 5 alcohol solvent, adding the resulting solution to a suitable amount of water and filtering.
- the present invention is further illustrated by the following example.
- Example L-2-acetoxypropionyl chloride (2 g; 166 mmoles) is added in 15 minutes to N,N-dimethylacetamide (23 ml), keeping the temperature at 10 - 15°C. The solution is heated to 23°C and, keeping this temperature, a solution of 5-ammmino-2 , 4 , 6-triiodoisophthaloyl dichloride (50 g; 84 mmoles) in N,N-dimethylacetamide (75 ml) is added in 6 hours. When the addition is completed, the mixture is kept under stirring for 15 hours. After this time, the starting product is lower than 1%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Removal Of Specific Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI962737 | 1996-12-24 | ||
IT96MI002737A IT1289521B1 (it) | 1996-12-24 | 1996-12-24 | Processo per la purificazione di un intermedio |
PCT/EP1997/007077 WO1998028261A1 (en) | 1996-12-24 | 1997-12-17 | A process for the purification of an intermediate useful in the synthesis of iodinated contrast media |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0888287A1 true EP0888287A1 (de) | 1999-01-07 |
Family
ID=11375488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97953838A Withdrawn EP0888287A1 (de) | 1996-12-24 | 1997-12-17 | Verfahren zur reinigung von einem zwischenprodukt zur herstellung von iodhaltigem kontrastmittel |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0888287A1 (de) |
AU (1) | AU5759098A (de) |
IN (1) | IN184019B (de) |
IT (1) | IT1289521B1 (de) |
NO (1) | NO308698B1 (de) |
WO (1) | WO1998028261A1 (de) |
ZA (1) | ZA9711505B (de) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH608189A5 (de) * | 1974-12-13 | 1978-12-29 | Savac Ag | |
IT1256162B (it) * | 1992-10-27 | 1995-11-29 | Zambon Spa | Processo per la preparazione di un intermedio della sintesi organica |
WO1996037460A1 (en) * | 1995-05-23 | 1996-11-28 | Fructamine S.P.A. | Process for the preparation of a dicarboxylic acid dichloride |
-
1996
- 1996-12-24 IT IT96MI002737A patent/IT1289521B1/it active IP Right Grant
-
1997
- 1997-12-17 AU AU57590/98A patent/AU5759098A/en not_active Abandoned
- 1997-12-17 EP EP97953838A patent/EP0888287A1/de not_active Withdrawn
- 1997-12-17 WO PCT/EP1997/007077 patent/WO1998028261A1/en not_active Application Discontinuation
- 1997-12-22 IN IN2960MA1997 patent/IN184019B/en unknown
- 1997-12-22 ZA ZA9711505A patent/ZA9711505B/xx unknown
-
1998
- 1998-08-21 NO NO983872A patent/NO308698B1/no not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
See references of WO9828261A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1998028261A1 (en) | 1998-07-02 |
NO983872L (no) | 1998-10-22 |
ITMI962737A1 (it) | 1998-06-24 |
AU5759098A (en) | 1998-07-17 |
NO308698B1 (no) | 2000-10-16 |
IT1289521B1 (it) | 1998-10-15 |
IN184019B (de) | 2000-06-03 |
ZA9711505B (en) | 1998-06-25 |
NO983872D0 (no) | 1998-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1150943B1 (de) | Herstellung von iodixanol | |
USRE36433E (en) | Process for the purifying of iopamidol | |
CA2389379C (en) | Method for the preparation of 5-carboxyphthalide | |
AU2005257478B2 (en) | Method for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl cyclopropane hydrochloride | |
AU2002229575B2 (en) | A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid | |
EP0888287A1 (de) | Verfahren zur reinigung von einem zwischenprodukt zur herstellung von iodhaltigem kontrastmittel | |
CA2543275C (en) | Process for the preparation of gabapentin | |
US5817861A (en) | Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media | |
EP0900196A1 (de) | Verfahren zur herstellung eines zwischenproduktes für die synthese von iodierten kontrastmitteln | |
US5091540A (en) | Process for preparing clotrimazole | |
US20050119351A1 (en) | Polymorphic forms of sertraline hydrochloride | |
JPH05286889A (ja) | アリール酢酸及びそれらのアルカリ金属塩の製造方法 | |
JPH1067718A (ja) | 4−ヒドロキシアニリン類の製法 | |
JP3042122B2 (ja) | N−シアノアセトアミジン誘導体の製造方法 | |
JP2000505064A (ja) | アミンのラセミ化法 | |
JP4408634B2 (ja) | ニトロイソキノリンの異性体分離方法 | |
US6008413A (en) | Process for recrystallizing 1,3-bis(aminophenoxy benzene) | |
US4945161A (en) | Process for the preparation of N,N'-bis-(2-hydroxy-ethyl) piperazine | |
EP0901461B1 (de) | Verfahren zur herstellung eines bei der herstellung von iodierten röntgenkontrastmitteln verwendbaren zwischenproduktes | |
JP2001510178A (ja) | 3−ヒドロキシ−2−メチル安息香酸の製造方法 | |
CN115197099A (zh) | N-Boc-1,4-苯二胺的制备方法 | |
JPH10101629A (ja) | 光学活性酪酸誘導体の製造方法 | |
JPH11335351A (ja) | N−カルボベンゾキシ−s−フェニルシステインの精製方法 | |
JP2000128826A (ja) | m−ハロゲノ安息香酸類の精製方法 | |
CA2448300A1 (en) | Process for preparing sertraline intermediates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980826 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE ES FR GB IE IT NL PT |
|
17Q | First examination report despatched |
Effective date: 19991021 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20000502 |